Shandong Polymer Biochemicals Co., Ltd.
Символ: 002476.SZ
SHZ
4.55
CNYПазарна цена днес
-1192.4868
Съотношение P/E
26.9703
Коефициент PEG
2.78B
MRK Cap
- 0.00%
Доходност на DIV
Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1259.11 | 305.6 | 401 | 361.8 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.31 | 0.3 | 0 | -18.6 | ||||||||||||||||
balance-sheet.row.net-receivables | 1010.97 | 365.1 | 248.1 | 127.9 | ||||||||||||||||
balance-sheet.row.inventory | 426.51 | 84.5 | 82 | 65.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 15.57 | 6.6 | 24.1 | 13.5 | ||||||||||||||||
balance-sheet.row.total-current-assets | 2712.15 | 761.7 | 755.1 | 568.9 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 745.39 | 182.4 | 200.8 | 390 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 278.39 | 79.5 | 8.5 | 31.5 | ||||||||||||||||
balance-sheet.row.tax-assets | 20.63 | 5.8 | 6.5 | 7.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 24.19 | 0.4 | 10.8 | 1.2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 1510.49 | 278.2 | 237.3 | 441.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.account-payables | 262.9 | 134.6 | 63.1 | 58.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 60.91 | 11.4 | 1.4 | 43.1 | ||||||||||||||||
balance-sheet.row.tax-payables | 14.29 | 3.2 | 3.9 | 2.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
Deferred Revenue Non Current | 4.77 | 1.3 | 1.5 | 1.7 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.34 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 40.68 | 22.8 | 12 | 0.5 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5.11 | 1.3 | 1.7 | 79.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
balance-sheet.row.total-liab | 497.51 | 170.4 | 152.4 | 188 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 2448 | 612 | 612 | 612 | ||||||||||||||||
balance-sheet.row.retained-earnings | 108.28 | 29.1 | -0.5 | -18.5 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 568.62 | 53.5 | 53.5 | 53.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 349.96 | 175 | 175 | 175 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3474.86 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.minority-interest | 250.28 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 3725.13 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4222.64 | - | - | - | ||||||||||||||||
Total Investments | 278.39 | 79.5 | 8.5 | 12.9 | ||||||||||||||||
balance-sheet.row.total-debt | 60.91 | 11.4 | 1.6 | 43.1 | ||||||||||||||||
balance-sheet.row.net-debt | -1198.2 | -294.2 | -399.4 | -318.8 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 9.59 | 34.9 | 38.8 | 40.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0.69 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 152.81 | -0.7 | 0.2 | -3.9 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -164.92 | -153.9 | -101.8 | -33.6 | ||||||||||||||||
cash-flows.row.account-receivables | -161.99 | -162 | -206.5 | -52.2 | ||||||||||||||||
cash-flows.row.inventory | -2.92 | -2.9 | -15.9 | 25.2 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 10.3 | 120.9 | -10.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 108.17 | 11.2 | 10.2 | 12.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 104.27 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | -71.17 | 5.5 | 117.5 | 2.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40 | -80 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.9 | 1.9 | 22.6 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 3.63 | 0.9 | -1.7 | 24.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -117.35 | -86.7 | 119.5 | 8.8 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.82 | -9.9 | -30.3 | -67 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -0.57 | -0.4 | -5.7 | -10.4 | ||||||||||||||||
cash-flows.row.other-financing-activites | 26.54 | 17.7 | -12 | 7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.15 | 7.3 | -48 | -70.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.91 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -8.02 | -157.6 | 36.6 | -29.1 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1184.3 | 240.6 | 398.2 | 361.5 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1192.32 | 398.2 | 361.5 | 390.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 104.27 | -78.2 | -34.8 | 32.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 92.56 | -93.2 | -54 | 14.9 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 479.79 | 592.3 | 657.2 | 447.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 384.21 | 462.7 | 557.1 | 363.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 95.58 | 129.6 | 100.1 | 83.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 18.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.99 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 98.38 | 100.8 | 76.8 | 58.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 482.59 | 563.5 | 633.9 | 421.9 | ||||||||||||||||
income-statement-row.row.interest-income | 6.13 | 6.7 | 5.4 | 5.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -4.07 | 36.9 | 38.8 | 40.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -4.59 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -0.52 | 30.7 | 25.3 | 26.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -2.13 | 31.1 | 17.7 | 17.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -0.07 | 1.4 | -0.2 | 3.9 | ||||||||||||||||
income-statement-row.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 |
Често задавани въпроси
Какво е Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) общи активи?
Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) общите активи са 1039968863.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 212096636.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.170.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.170.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.004.
Какъв е общият приход на предприятието?
Общият приход е -0.001.
Каква е Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 29630378.000.
Какъв е общият дълг на фирмата?
Общият дълг е 11381167.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 100833128.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 314019731.000.